HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Muscle relaxants in the treatment of idiopathic trigeminal neuralgia (author's transl)].

Abstract
In 195 patients with idiopathic trigeminal neuralgias, atypical facial neuralgia or zoster neuralgia in the face it was shown that, in the initial stages of these diseases, the efficacy of the always satisfactory medicinal treatment with an anticonvulsant (hydantoin or carbamezathine) can be increased by combination with a muscle relaxant (especially chlormezanone). Medicinal therapy is then still frequently possible without side effects and operative treatment (Frazier-Spiller's retrogasserian neurotomy) can be postponed.
AuthorsH H von Albert
JournalMMW, Munchener medizinische Wochenschrift (MMW Munch Med Wochenschr) Vol. 117 Issue 35 Pg. 1379-82 (Aug 29 1975) ISSN: 0341-3098 [Print] Germany
Vernacular TitleMuskelrelaxantien zur Behandlung der idiopathischen Trigeminusneuralgie
PMID809678 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Aminobutyrates
  • Anticonvulsants
  • Drug Combinations
  • Muscle Relaxants, Central
  • Pyridines
  • Carisoprodol
  • Orphenadrine
  • Chlormezanone
  • Chlorphenesin
Topics
  • Aminobutyrates (therapeutic use)
  • Anticonvulsants (adverse effects, therapeutic use)
  • Carisoprodol (therapeutic use)
  • Chlormezanone (therapeutic use)
  • Chlorphenesin (therapeutic use)
  • Drug Combinations
  • Drug Therapy, Combination
  • Evaluation Studies as Topic
  • Humans
  • Long-Term Care
  • Muscle Relaxants, Central (adverse effects, therapeutic use)
  • Orphenadrine (therapeutic use)
  • Pyridines (therapeutic use)
  • Trigeminal Neuralgia (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: